Literature DB >> 27988987

Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis.

Surbhi Grover1, Sommer Nurkic2, Marie Diener-West3, Shayna L Showalter4.   

Abstract

Randomized clinical trials have demonstrated equivalency in survival outcomes for early stage breast cancer patients treated with either mastectomy or breast-conserving surgery (BCS) with radiation. Recent, state-level data confirm comparable survival outcomes. Using Surveillance Epidemiology and End Research (SEER) data, we sought to evaluate survival outcomes among patients with early stage breast cancer treated with mastectomy, BCS with whole breast irradiation (BCS + WBI), or BCS with accelerated partial breast irradiation (BCS + APBI). Data on women 50 years or older diagnosed with a node negative invasive breast cancer (≤3 cm in size) between 1995 and 2009 were extracted from the SEER data base. Women treated with mastectomy alone or BCS with radiation were eligible for analysis. Kaplan-Meier estimates and Cox proportional hazard models were used to compare overall survival (OS) and cancer-specific survival (CSS) among the treatment groups. 150,171 women fulfilled inclusion criteria. OS was significantly improved among women treated with BCS and WBI or BCS and APBI compared to mastectomy alone. Adjusted hazard ratios for death in BCS with WBI or APBI (versus mastectomy alone) were 0.73 (95% CI: 0.71, 0.76) and 0.68 (95% CI: 0.58, 0.79), respectively. Adjusted CSS was also significantly improved in patients treated with BCS and WBI (HR 0.80, 95% CI: 0.76, 0.85) as compared to mastectomy. BCS with radiation (WBI or APBI) was associated with significantly improved OS and CSS, versus mastectomy alone. These results support the use of BCS with WBI or APBI (in well selected patients) for the treatment of breast cancer.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  accelerated partial breast irradiation; breast-conserving therapy; mastectomy

Mesh:

Year:  2016        PMID: 27988987     DOI: 10.1111/tbj.12729

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

1.  Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3).

Authors:  Gustavo R Sarria; Grit Welzel; Martin Polednik; Frederik Wenz; Yasser Abo-Madyan
Journal:  Front Oncol       Date:  2022-05-05       Impact factor: 5.738

2.  Foot posture in female patients 5 years after breast-conserving surgery: a case-control study.

Authors:  Iwona Głowacka-Mrotek; Magdalena Sowa; Tomasz Nowikiewicz; Zygmunt Siedlecki; Wojciech Hagner; Wojciech Zegarski
Journal:  Breast Cancer       Date:  2018-01-24       Impact factor: 4.239

3.  Frequency of whole breast irradiation (WBRT) after intraoperative radiotherapy (IORT) is strongly influenced by institutional protocol qualification criteria.

Authors:  Michał Falco; Bartłomiej Masojć; Marta Milchert-Leszczyńska; Andrzej Kram
Journal:  Rep Pract Oncol Radiother       Date:  2017-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.